SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotransplant(BTRN) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (1267)3/5/2002 9:22:25 AM
From: Arthur Radley  Read Replies (1) | Respond to of 1475
 
I agree....I get an email it seems every day from this outfit. Appears they are taking the scatter gun approach...firing away and hoping something will stick.
With my limited knowledge of GVH rejection, I don't see how this approach will solve the problem and therefore be needed as a treatment method. From what I know, the rejection isn't confined to the blood vessels to the transplanted organ... so why bother with this trial?